BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20002765)

  • 1. Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expenditures.
    Basu A; Yin W; Alexander GC
    Health Serv Res; 2010 Feb; 45(1):133-51. PubMed ID: 20002765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the Medicare Part D prescription benefit on drug utilization and expenditures.
    Yin W; Basu A; Zhang JX; Rabbani A; Meltzer DO; Alexander GC
    Ann Intern Med; 2008 Feb; 148(3):169-77. PubMed ID: 18180465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations Between Medicare Part D and Out-of-Pocket Spending, HIV Viral Load, Adherence, and ADAP Use in Dual Eligibles With HIV.
    Belenky N; Pence BW; Cole SR; Dusetzina SB; Edmonds A; Oberlander J; Plankey MW; Adedimeji A; Wilson TE; Cohen J; Cohen MH; Milam JE; Golub ET; Adimora AA
    Med Care; 2018 Jan; 56(1):47-53. PubMed ID: 29227443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more?
    Mott DA; Thorpe JM; Thorpe CT; Kreling DH; Gadkari AS
    Res Social Adm Pharm; 2010 Jun; 6(2):90-9. PubMed ID: 20511108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition to Medicare Part D: an early snapshot of barriers experienced by younger dual eligibles with disabilities.
    Hall JP; Kurth NK; Moore JM
    Am J Manag Care; 2007 Jan; 13(1):14-8. PubMed ID: 17227199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicaid prescription drug utilization and expenditures following Part D.
    Farley JF; Dusetzina SB
    J Health Care Poor Underserved; 2010 May; 21(2):715-28. PubMed ID: 20453368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007.
    Briesacher BA; Zhao Y; Madden JM; Zhang F; Adams AS; Tjia J; Ross-Degnan D; Gurwitz JH; Soumerai SB
    Med Care; 2011 Sep; 49(9):834-41. PubMed ID: 21544002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV.
    Belenky N; Pence BW; Cole SR; Dusetzina SB; Edmonds A; Oberlander J; Plankey M; Adedimeji A; Wilson TE; Cohen J; Cohen MH; Milam JE; Adimora AA
    AIDS Care; 2019 Apr; 31(4):505-512. PubMed ID: 30189747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM
    JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Medicare Part D doughnut hole: effect on pharmacy utilization.
    Sun SX; Lee KY
    Manag Care Interface; 2007 Sep; 20(9):51-5, 59. PubMed ID: 18161394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual eligibles with mental disorders and Medicare part D: how are they faring?
    Donohue JM; Huskamp HA; Zuvekas SH
    Health Aff (Millwood); 2009; 28(3):746-59. PubMed ID: 19414883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug benefit changes under Medicare Advantage Part D: heterogeneous effects on pharmaceutical use and expenditures.
    Ettner SL; Steers WN; Turk N; Quiter ES; Mangione CM
    J Gen Intern Med; 2011 Oct; 26(10):1195-200. PubMed ID: 21710313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Medicare Part D on Prescription Drug Spending and Health Care Use: 6 Years of Follow-up, 2007-2012.
    Park T; Jung J
    J Manag Care Spec Pharm; 2017 Jan; 23(1):5-12. PubMed ID: 28025927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and ethnic differences in drug expenditures and access under Medicare Part D.
    Chen J; Rizzo JA; Ortega AN
    J Health Care Poor Underserved; 2011 Aug; 22(3):1059-74. PubMed ID: 21841296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008.
    Cheng LI; Rascati KL
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1423-9. PubMed ID: 22508663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care utilization among Medicare-Medicaid dual eligibles: a count data analysis.
    Moon S; Shin J
    BMC Public Health; 2006 Apr; 6():88. PubMed ID: 16595021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term care use on Medicare and Medicaid expenditures for dual eligible and non-dual eligible elderly beneficiaries.
    Kane RL; Wysocki A; Parashuram S; Shippee T; Lum T
    Medicare Medicaid Res Rev; 2013; 3(3):. PubMed ID: 24753971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Early Dual-Eligible Special Needs Plans on Health Expenditure.
    Zhang Y; Diana ML
    Health Serv Res; 2018 Aug; 53(4):2165-2184. PubMed ID: 29044547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Medicare Part D on health care utilization for non-elderly Medicare recipients with disabilities.
    Nelson RE; Nelson SL; Huttner B; Gundlapalli A
    Disabil Health J; 2014 Jan; 7(1):64-9. PubMed ID: 24411509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.